Primary immunization at 3, 4.5, and 6 months and boosting between 15 and 27 months of
age with combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus …

Background. We estimated the vaccine effectiveness (VE) of tetanus-diphtheria-acellular
pertussis vaccine (Tdap) for preventing pertussis among adolescents during a statewide …

Immunogenicity and reactogenicity of DTPa and reduced antigen dTpa booster vaccines
were compared to a hepatitis A control vaccine in DTPa-primed toddlers aged 18–20 …

BACKGROUND: Older adults, especially those over 65 years, are at risk of more severe
morbidity from diphtheria, tetanus and pertussis and may transmit pertussis to unvaccinated …

Background: In the United States, diphtheria-tetanus-acellular pertussis (DTaP) and
inactivated poliovirus (IPV) booster vaccinations are recommended for children 4–6 years of …

We assessed the immunogenicity and safety of the combined diphtheria-tetanus-acellular
pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …

Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …

Sustained high incidence of pertussis, particularly amongst unvaccinated infants, is of
concern. Inclusion of pertussis vaccination with tetanus and low dose diphtheria (Td) …

Recurrence of adverse events, the effect of site of injection, and concurrent administration of
oral polio vaccine (OPV) and hepatitis B vaccine (HBV) on reactogenicity were assessed in …

Background In 2005, an acellular pertussis-containing DTP-IPV-Hib vaccine for infants
replaced the whole-cell combination vaccine in the National Immunisation Programme of the …